Pharma CEO raises EpiPen price by 400%, and gets a 671% raise

Well, if there isn’t a reversal because of outrage, then I guess we’ll find out. Maybe this can be a test case to see how well the free market keeps drug costs down. Care to make a wager?

3 Likes